You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API hydrochlorothiazide


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing hydrochlorothiazide

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Actavis Pharma Inc HYDROCHLOROTHIAZIDE hydrochlorothiazide 0591-0347 D&C RED NO. 28
Actavis Pharma Inc HYDROCHLOROTHIAZIDE hydrochlorothiazide 0591-0347 D&C YELLOW NO. 10
Actavis Pharma Inc HYDROCHLOROTHIAZIDE hydrochlorothiazide 0591-0347 FD&C BLUE NO. 1
Actavis Pharma Inc HYDROCHLOROTHIAZIDE hydrochlorothiazide 0591-0347 FD&C BLUE NO. 2
Actavis Pharma Inc HYDROCHLOROTHIAZIDE hydrochlorothiazide 0591-0347 FD&C RED NO. 40
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing hydrochlorothiazide

Company Ingredient NDC Excipient
Actavis Pharma Inc hydrochlorothiazide 0228-2820 CALCIUM STEARATE
Actavis Pharma Inc hydrochlorothiazide 0228-2820 FD&C YELLOW NO. 6
Actavis Pharma Inc hydrochlorothiazide 0228-2820 LACTOSE MONOHYDRATE
Actavis Pharma Inc hydrochlorothiazide 0228-2820 SODIUM LAURYL SULFATE
Actavis Pharma Inc hydrochlorothiazide 0228-2820 STARCH, CORN
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for hydrochlorothiazide

Excipient focus: ACACIA

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: ANHYDROUS LACTOSE

hydrochlorothiazide drug variants containing ANHYDROUS LACTOSE

Company Ingredient NDC
Liberty Pharmaceuticals Inc hydrochlorothiazide 0440-1595
NCS HealthCare of KY LLC dba Vangard Labs hydrochlorothiazide 0615-8449
NCS HealthCare of KY LLC dba Vangard Labs hydrochlorothiazide 0615-8450
Rebel Distributors Corp hydrochlorothiazide 21695-538
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc hydrochlorothiazide 23155-009
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: BENZYL ALCOHOL

Excipient focus: BUTYL ALCOHOL

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

Excipient focus: CALCIUM STEARATE

Excipient focus: CARAMEL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
Mylan Pharmaceuticals Inc hydrochlorothiazide 0378-0810
Lannett Company Inc hydrochlorothiazide 0527-1413
NCS HealthCare of KY Inc dba Vangard Labs hydrochlorothiazide 0615-1561
NCS HealthCare of KY Inc dba Vangard Labs hydrochlorothiazide 0615-8036
NCS HealthCare of KY LLC dba Vangard Labs hydrochlorothiazide 0615-8449
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: CETYLPYRIDINIUM CHLORIDE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: D&C RED NO. 28

Excipient focus: D&C RED NO. 33

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: DOCUSATE SODIUM

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C RED NO. 40 ALUMINUM LAKE

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCINE

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

hydrochlorothiazide drug variants not containing LACTOSE MONOHYDRATE

Company Ingredient NDC
Mylan Pharmaceuticals Inc hydrochlorothiazide 0378-0810
Liberty Pharmaceuticals Inc hydrochlorothiazide 0440-1595
NCS HealthCare of KY Inc dba Vangard Labs hydrochlorothiazide 0615-8036
NCS HealthCare of KY LLC dba Vangard Labs hydrochlorothiazide 0615-8449
NCS HealthCare of KY LLC dba Vangard Labs hydrochlorothiazide 0615-8450
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: METHYL ALCOHOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MOLASSES

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYSORBATE 80

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POTASSIUM SORBATE

Excipient focus: POVIDONE

Excipient focus: POWDERED CELLULOSE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: RED 40 LAKE

Excipient focus: SHELLAC

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN

hydrochlorothiazide drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN

Company Ingredient NDC
NCS HealthCare of KY LLC dba Vangard Labs hydrochlorothiazide 0615-8449
Aphena Pharma Solutions - Tennessee LLC hydrochlorothiazide 43353-240
A-S Medication Solutions hydrochlorothiazide 50090-6372
Golden State Medical Supply Inc hydrochlorothiazide 51407-330
Northwind Pharmaceuticals LLC hydrochlorothiazide 51655-674
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: STEARIC ACID

Excipient focus: SUCRALOSE

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: XANTHAN GUM

Excipient focus: ZEA MAYS

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links